Methyl N-acetylanthranilate
Common Name: |
Methyl N-acetylanthranilate |
IUPAC Name: |
methyl 2-acetamidobenzoate |
Molecular Formula: |
C10H11NO3 |
SMILES: |
CC(=O)NC1=CC=CC=C1C(=O)OC |
Inchi: |
1S/C10H11NO3/c1-7(12)11-9-6-4-3-5-8(9)10(13)14-2/h3-6H,1-2H3,(H,11,12) |
Inchi Key: |
UYQKZKVNYKOXHG-UHFFFAOYSA-N |
Cas No: |
2719-08--6 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
193.20 |
Mass (g/mol) |
193.074 |
Molar Refractivity |
52.03 |
Net Charge |
|
HBD |
1 |
HBA |
3 |
Rt Bonds |
4 |
Rings |
1 |
TPSA |
55.40 |
Hetero Atoms |
4 |
Heavy Atoms |
14 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
98.00 to 101.00 |
Boiling Point (°C@760.00mm Hg) |
376.34 |
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.20 |
LogP |
1.432 |
iLOGP |
2.06 |
XLOGP3 |
1.65 |
WLOGP |
1.24 |
MLOGP |
1.41 |
ESOL Log S |
-2.13 |
ESOL Solubility (mg/ml) |
1.43 |
ESOL Solubility (mol/l) |
0.007 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.43 |
Ali Solubility (mg/ml) |
0.72 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.87 |
Silicos-IT Solubility (mg/ml) |
0.26 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.31 |
Bioavailability Score |
0.55 |
Caco2 |
0 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.561 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |